Effect of SARSCoV2 (COVID-19) Vaccination in Type 1 Diabetes (CoVaxT1D)
NCT04905823
·
clinicaltrials.gov ↗
COMPLETED
Status
600
Enrollment
OTHER
Sponsor class
Conditions
Type 1 Diabetes
Interventions
DIAGNOSTIC_TEST:
blood test
Sponsor
Paolo Fiorina, MD
Collaborators
[object Object]